Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
SEC Filings
Plan is for Company to File All Outstanding Filings as They Are Completed. Proto Script
Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a
durable medical equipment provider, announced today that the Company is in process of updating
its fillings with SEC.
Rancho Cucamonga, CA, February 05, 2018 --(PR.com)-- Michelle Rico, CEO of Proto Script
Pharmaceutical Corp. stated: “We have been diligently working with our SEC attorneys and auditors to
bring the Company fully current in its filings and are pleased that we are close to completing this project.
We intend to file all outstanding documents as soon as they are completed. We believe this should give
the markets more confidence in the Company and its officers."
She continued: “Once we have achieved this first goal to be fully current and have that behind us, we can
change our focus on increasing the Company's footprint in the medical equipment marketplace. As the
market sector continues its rapid growth, we will be in the process of building valuable new relationships
to increase inroads to new projects in new territories; while at the same time our team will be also
exploring other sectors to complement our current company growth strategies, assets, adding more
in-house talent and products to service our business as we grow.”
She continued: “We will continue to keep our shareholders updated as we enter 2018 and will be timely
releasing a continuing amount of information with the goal of being fully transparent.”
PSP Homecare currently operates power wheelchair and mobility scooter sale/repair facilities in Las
Vegas, Nevada, and Rancho-Cucamonga.
Proto Script Pharmaceutical Corp. files reports with the Securities & Exchange Commission at
www.sec.gov.
This press release was written by PubCoPR.com - For more information: info@PubCoPR.com
Page 1/3
PR.com Press Release Distribution Terms of Use
Cautionary Language Concerning Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions
of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of
historical fact, including those with respect to the Company's mission statement and growth strategy, are
"forward-looking statements." Although management believes that such forward-looking statements are
reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking
statements involve a number of risks and uncertainties, which could cause the Company's future results to
differ materially from those anticipated. Potential risks and uncertainties include, among others, general
economic conditions and conditions affecting the industries in which the Company operates; the
uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on
acceptable terms or at all. Additional information regarding the factors that may cause actual results to
differ materially from these forward-looking statements is available in the Company's filings with the
SEC. The Company assumes no obligation to update any of the information contained or referenced in
this press release.
Contact:
Michelle Rico, CEO
855-476-7679
Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Proto-Script Phamaceutical Corp.
Michelle Rico
855-476-7679
Contact via Email
PspHomecare.com
News Image:
Page 3/3
PR.com Press Release Distribution Terms of Use